MedicineHematologyOncologyChemotherapyHepatologySurgical OncologyCirrhosisHepatobiliary DiseaseHepatobiliary SurgeryHepatocellular CarcinomaLiver CancerLiver DiseaseClinical Survival RatesHepatic MalignancyHepatic TumorsHepatocellular Carcinoma TreatmentImmune Function ImpairmentInterferon ProductionSurvival RatesTotal Serum Bilirubin
BACKGROUND: The aim of this study was to compare the outcome after simultaneous hepatectomy and splenectomy with that after hepatectomy alone for hepatocellular carcinoma with associated hypersplenism. METHODS: Two hundred and four patients with hepatocellular carcinoma and cirrhotic hypersplenism were divided non-randomly into two groups. Ninety-four underwent simultaneous hepatectomy and splenectomy and 110 underwent hepatectomy alone. White blood cell (WBC) and platelet counts, total serum bilirubin levels, immune function, incidence of complications and 5-year survival rates in the two groups were compared. RESULTS: WBC and platelet counts, distribution of T cell subsets, and levels of bilirubin, interferon gamma and interleukin 2 were different between the two groups after operation. All patients who underwent hepatectomy and splenectomy but only 15.5 per cent of those who had hepatectomy alone completed adjuvant chemotherapy. The 5-year tumour-free survival rate was significantly higher after hepatectomy and splenectomy than after hepatectomy alone (37 versus 27.3 per cent; P = 0.003), although overall survival rates were similar. CONCLUSION: Simultaneous hepatectomy and splenectomy was associated with improved 5-year tumour-free survival in patients with hepatocellular carcinoma and hypersplenism.
22
Surgery of the liver and biliary tract
Digestive and Liver Disease · 2003 · 468 citations
Surgery of the liver and biliary tract
K.E. Behrns · Gastroenterology · 2001 · 389 citations · Full text
Surgery of small hepatocellular carcinoma. Analysis of 144 cases
Zhao–You Tang, Ye‐Qin Yu, Xin‐Da Zhou et al. · Cancer · 1989 · 132 citations